C07D233/00- Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings. A61P43/00- Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00. A61P3/10- Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. A61P3/08- Drugs for disorders of the metabolism for glucose homeostasis. A61P3/04- Anorexiants Antiobesity agents. A61P3/00- Drugs for disorders of the metabolism. A61P29/00- Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents Non-steroidal anti-inflammatory drugs (NSAIDs). nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia A61P25/28- Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. A61P25/00- Drugs for disorders of the nervous system. 
A61P13/12- Drugs for disorders of the urinary system of the kidneys. A61P13/00- Drugs for disorders of the urinary system. A61P- SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. A61K31/513- Pyrimidines Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings A61K31/506- Pyrimidines Hydrogenated pyrimidines, e.g. A61K31/505- Pyrimidines Hydrogenated pyrimidines, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. A61K31/495- Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. A61K31/395- Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. A61K31/00- Medicinal preparations containing organic active ingredients. A61K- PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES. A61- MEDICAL OR VETERINARY SCIENCE HYGIENE. C07D239/32- One oxygen, sulfur or nitrogen atom. C07D239/56- One oxygen atom and one sulfur atom. C07D239/46- Two or more oxygen, sulfur or nitrogen atoms. C07D239/28- Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms. C07D239/24- Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members. C07D239/02- Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings. C07D239/00- Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings. 
239000003954 decarboxylase inhibitor Substances 0.000 title 1. Application granted granted Critical Publication of ES2901114T3 publication Critical patent/ES2901114T3/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority to US201462043853P priority Critical Application filed by Tes Pharma Srl filed Critical Tes Pharma Srl Priority to PCT/EP2015/069808 priority patent/WO2016030534A1/en First worldwide family litigation filed litigation Critical (T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Original Assignee Tes Pharma Srl Priority date (The priority date is an assumption and is not a legal conclusion. 
Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Roberto Pellicciari Johan Auwerx Nadia Raffaelli Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES15756408T Other languages Spanish ( es)
Hydrogen symbol pdf#
Alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase inhibitorsĭownload PDF Info Publication number ES2901114T3 ES2901114T3 ES15756408T ES15756408T ES2901114T3 ES 2901114 T3 ES2901114 T3 ES 2901114T3 ES 15756408 T ES15756408 T ES 15756408T ES 15756408 T ES15756408 T ES 15756408T ES 2901114 T3 ES2901114 T3 ES 2901114T3 Authority ES Spain Prior art keywords formula disease compound alkyl disorder Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.
0 kommentar(er)
